世界の酢酸グラチラマー市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Glatiramer Acetate Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、酢酸グラチラマーの世界市場を広く調査・分析し、今後の市場展望をまとめております。酢酸グラチラマーの種類別市場規模(ブランド医薬品、ジェネリック医薬品)、用途別市場規模(病院、薬局、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Teva、NATCO Pharma、Mylan、Novartis、HYBIO
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ブランド医薬品、ジェネリック医薬品
・用途別分析2016年-2026年:病院、薬局、その他
・酢酸グラチラマーの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・酢酸グラチラマーのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・酢酸グラチラマーのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・酢酸グラチラマーの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・酢酸グラチラマーの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Glatiramer Acetate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Glatiramer Acetate size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Glatiramer Acetate market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Glatiramer Acetate market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Brand Medicine
Generic Drug

Market segment by Application can be divided into
Hospital
Pharmacy
Other

The key market players for global Glatiramer Acetate market are listed below:
Teva
NATCO Pharma
Mylan
Novartis
HYBIO

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Glatiramer Acetate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Glatiramer Acetate, with price, sales, revenue and global market share of Glatiramer Acetate in 2018 and 2019.
Chapter 3, the Glatiramer Acetate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glatiramer Acetate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Glatiramer Acetate market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Glatiramer Acetate sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Glatiramer Acetate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glatiramer Acetate Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Brand Medicine
1.2.3 Generic Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Glatiramer Acetate Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Glatiramer Acetate Market Size & Forecast
1.4.1 Global Glatiramer Acetate Sales in Value (2016-2026))
1.4.2 Global Glatiramer Acetate Sales in Volume (2016-2026)
1.4.3 Global Glatiramer Acetate Price by Type (2016-2026) & (USD/Unit)
1.5 Global Glatiramer Acetate Production Capacity Analysis
1.5.1 Global Glatiramer Acetate Total Production Capacity (2016-2026)
1.5.2 Global Glatiramer Acetate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glatiramer Acetate Market Drivers
1.6.2 Glatiramer Acetate Market Restraints
1.6.3 Glatiramer Acetate Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Glatiramer Acetate Product and Services
2.1.4 Teva Glatiramer Acetate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 NATCO Pharma
2.2.1 NATCO Pharma Details
2.2.2 NATCO Pharma Major Business
2.2.3 NATCO Pharma Glatiramer Acetate Product and Services
2.2.4 NATCO Pharma Glatiramer Acetate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Glatiramer Acetate Product and Services
2.3.4 Mylan Glatiramer Acetate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Glatiramer Acetate Product and Services
2.4.4 Novartis Glatiramer Acetate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 HYBIO
2.5.1 HYBIO Details
2.5.2 HYBIO Major Business
2.5.3 HYBIO Glatiramer Acetate Product and Services
2.5.4 HYBIO Glatiramer Acetate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Glatiramer Acetate Sales by Manufacturer
3.1 Global Glatiramer Acetate Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Glatiramer Acetate Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Glatiramer Acetate
3.4 Market Concentration Rate
3.4.1 Top 3 Glatiramer Acetate Manufacturer Market Share
3.4.2 Top 6 Glatiramer Acetate Manufacturer Market Share
3.5 Global Glatiramer Acetate Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Glatiramer Acetate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glatiramer Acetate Market Size by Region
4.1.1 Global Glatiramer Acetate Sales in Volume by Region (2016-2026)
4.1.2 Global Glatiramer Acetate Revenue by Region (2016-2026)
4.2 North America Glatiramer Acetate Revenue (2016-2026)
4.3 Europe Glatiramer Acetate Revenue (2016-2026)
4.4 Asia-Pacific Glatiramer Acetate Revenue (2016-2026)
4.5 South America Glatiramer Acetate Revenue (2016-2026)
4.6 Middle East and Africa Glatiramer Acetate Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Glatiramer Acetate Sales in Volume by Type (2016-2026)
5.2 Global Glatiramer Acetate Revenue by Type (2016-2026)
5.3 Global Glatiramer Acetate Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Glatiramer Acetate Sales in Volume by Application (2016-2026)
6.2 Global Glatiramer Acetate Revenue by Application (2016-2026)
6.3 Global Glatiramer Acetate Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Glatiramer Acetate Sales by Type (2016-2026)
7.2 North America Glatiramer Acetate Sales by Application (2016-2026)
7.3 North America Glatiramer Acetate Market Size by Country
7.3.1 North America Glatiramer Acetate Sales in Volume by Country (2016-2026)
7.3.2 North America Glatiramer Acetate Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Glatiramer Acetate Sales by Type (2016-2026)
8.2 Europe Glatiramer Acetate Sales by Application (2016-2026)
8.3 Europe Glatiramer Acetate Market Size by Country
8.3.1 Europe Glatiramer Acetate Sales in Volume by Country (2016-2026)
8.3.2 Europe Glatiramer Acetate Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Glatiramer Acetate Sales by Type (2016-2026)
9.2 Asia-Pacific Glatiramer Acetate Sales by Application (2016-2026)
9.3 Asia-Pacific Glatiramer Acetate Market Size by Region
9.3.1 Asia-Pacific Glatiramer Acetate Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Glatiramer Acetate Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Glatiramer Acetate Sales by Type (2016-2026)
10.2 South America Glatiramer Acetate Sales by Application (2016-2026)
10.3 South America Glatiramer Acetate Market Size by Country
10.3.1 South America Glatiramer Acetate Sales in Volume by Country (2016-2026)
10.3.2 South America Glatiramer Acetate Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glatiramer Acetate Sales by Type (2016-2026)
11.2 Middle East & Africa Glatiramer Acetate Sales by Application (2016-2026)
11.3 Middle East & Africa Glatiramer Acetate Market Size by Country
11.3.1 Middle East & Africa Glatiramer Acetate Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Glatiramer Acetate Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Glatiramer Acetate Typical Distributors
12.3 Glatiramer Acetate Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

...

【掲載企業】

Teva、NATCO Pharma、Mylan、Novartis、HYBIO

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の酢酸グラチラマー市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Glatiramer Acetate Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。